The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture…
We have great news to share! The 2022 AIM-HI Women’s Venture Competition is Now Open for Applications!
This unique funding program, now in its third year, provides investment, coaching, and networking opportunities to women-led oncology startups. Companies with a woman in senior leadership who has an equity stake are eligible to apply worldwide.
If you are seeking Series A or earlier investment funding, make sure to submit an online application by February 28, 2022. The winning company will receive up to $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. Cash prizes will be awarded to the top three finalists.
Contestants will also have opportunities to:
- Obtain insightful feedback from world-class selection and judging committees
- Receive recognition, visibility, and introductions to cancer experts worldwide
- Network with key opinion leaders, business executives, investors, and fellow women entrepreneurs in the life science startup ecosystem